Back to search
FDAFDA · Food and drugs·Recall number D-66458-1

Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92

Published November 13, 2013 · Recall initiated: October 9, 2013

Summary

FDA records drug Class II recall D-66458-1, published November 13, 2013 and initiated October 9, 2013. Recalling firm: Sandoz, Inc; Status: Terminated; Reported quantity: 692 bottles (90 count); Lot: Lot DJ2744, Exp 12/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz, Inc
Distributor
Nationwide
Lot
Lot DJ2744, Exp 12/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ropinirole, extended-release tablets, 2 mg, 90 count bottle, Rx only, Manufactured in India by Sandoz Private Ltd, for Sandoz Inc, Princeton, NJ 08540, NDC 0781-5780-92 recalled?

Yes. FDA published recall D-66458-1 on November 13, 2013. Reported hazard: Cross contamination with other products: Sandoz is recalling certain lots of Ropinirole Extended Release Tablets 2 mg due to the potential presence of carryover coming from the previously manufactured product, mycophenolate mofetil.

What should I do if I have this product?

Voluntary: Firm initiated · Letter